 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/23/2023 |
$2.27 |
$2.30 |
$2.25 |
$2.29 |
24.10K | | 01/24/2023 |
$2.25 |
$2.31 |
$2.25 |
$2.27 |
33.00K | | 01/25/2023 |
$2.24 |
$2.30 |
$2.23 |
$2.30 |
32.30K | | 01/26/2023 |
$2.33 |
$2.39 |
$2.24 |
$2.27 |
23.00K | | 01/27/2023 |
$2.31 |
$2.31 |
$2.18 |
$2.22 |
40.10K |
|
|
| ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. | |
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on January 23, 2023, ABIO opened at $2.27, traded as high as $2.30 and as low as $2.25, and closed at $2.29. Trading volume was a total of 24.10K shares. On January 24, 2023, ABIO opened at $2.25, traded as high as $2.31 and as low as $2.25, and closed at $2.27. Trading volume was a total of 33.00K shares. On January 25, 2023, ABIO opened at $2.24, traded as high as $2.30 and as low as $2.23, and closed at $2.30. Trading volume was a total of 32.30K shares. On January 26, 2023, ABIO opened at $2.33, traded as high as $2.39 and as low as $2.24, and closed at $2.27. Trading volume was a total of 23.00K shares. On January 27, 2023, ABIO opened at $2.31, traded as high as $2.31 and as low as $2.18, and closed at $2.22. Trading volume was a total of 40.10K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/30/2013 |
|
| End date: |
01/27/2023 |
|
| Start price/share: |
$514.08 |
|
| End price/share: |
$2.22 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.57% |
|
| Average Annual Total Return: |
-41.99% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$43.22 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 01/23/2023 | $2.29 | | 01/24/2023 | $2.27 | | 01/25/2023 | $2.30 | | 01/26/2023 | $2.27 | | 01/27/2023 | $2.22 |
|
|
Free ABIO Email Alerts:
